We are live on ! Find out more
CTXRW

Citius Pharmaceuticals, Inc. Warrant
CTXRW

Delisted

CTXRW was delisted on the 8th of August, 2022.

Back to rankings

1 hedge funds and large institutions have $1K invested in Citius Pharmaceuticals, Inc. Warrant in 2019 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

67% less capital invested

Capital invested by funds: $3K → $1K (-$2K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.52K

Top Sellers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
1
UBS Group
Switzerland
$1K +$1.52K +5,400 +697%
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
– -$3K -11,049 Closed

CTXRW Hedge Fund Activity: Q2 2019 in Review

1 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in Citius Pharmaceuticals, Inc. Warrant (CTXRW) for Q2 2019, worth a combined $1K — down 67% from $3K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of CTXRW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.52K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $3K sold.

  • 1 institutional investor held Citius Pharmaceuticals, Inc. Warrant (CTXRW) as of Q2 2019, down from 2 in Q1 2019.
  • Funds reported $1K of Citius Pharmaceuticals, Inc. Warrant stock for Q2 2019, down 67% quarter-over-quarter.
  • 0 funds opened new Citius Pharmaceuticals, Inc. Warrant positions in Q2 2019 and 1 closed out, a net change of -1 holder.
  • The largest Citius Pharmaceuticals, Inc. Warrant buyer in Q2 2019 was UBS Group, an estimated $1.52K added.
  • The largest Citius Pharmaceuticals, Inc. Warrant seller in Q2 2019 was Susquehanna International Group, an estimated $3K sold.

Based on aggregated 13F filings for Q2 2019.